Drug Markets/Isradipine

Isradipine

4 NDCs across 2 manufacturers|4 Generic,0 Brand

Isradipine is used to treat variant angina pectoris and hypertension, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 20, 1990, and the first generic was approved Jan 5, 2006. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1 million on Isradipine across 6,306 claims for 1,637 beneficiaries.

Isradipine is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $1.16 to $1.66 per EAa 43% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

4G / 0B

Manufacturers

2

competing in market

Price Spread

$1.16 – $1.66

per EA

7d Activity

220 flat

avg -7.3% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Isradipine used to treat?

Isradipine is used to treat variant angina pectoris and hypertension, per the National Library of Medicine's MED-RT classification.

When did Isradipine become available as a generic?

FDA approved the first generic Isradipine (ANDA) on Jan 5, 2006. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Isradipine?

In 2024, Medicare Part D spent $1 million on Isradipine across 6,306 claims for 1,637 beneficiaries.

How many Isradipine products are on the market?

The Isradipine drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.

What is the price range for Isradipine?

NADAC reference prices for Isradipine range from $1.1589 to $1.6597 per EA — a 43% difference between cheapest and most expensive.

Which manufacturers make Isradipine?

2 manufacturers list Isradipine in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (2), Elite Laboratories, Inc. (2).

How has the price of Isradipine changed recently?

Over the past 7 days, 2 Isradipine NDCs rose and 2 fell, with a market-wide average change of -7.3%.